{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:45:57Z","timestamp":1790891157979,"version":"4.1.0"},"reference-count":9,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,9,25]]},"abstract":"<jats:p>The pure red cell aplasia (PRCA) is an uncommon side effect of isoniazid. We describe a 28-year-old man who developed a severe anaemia caused by PRCA. The patient received antituberculous therapy including isoniazid for his pulmonary tuberculosis. On discontinuation of isoniazid, the anaemia recovered promptly. PRCA should be considered in case of unexplained anaemia during isoniazid treatment.<\/jats:p>","DOI":"10.1136\/bcr-2018-226134","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T07:15:17Z","timestamp":1538982917000},"page":"bcr-2018-226134","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Isoniazid-induced pure red cell aplasia"],"prefix":"10.1136","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-6384","authenticated-orcid":false,"given":"Subraya Krishna","family":"Holla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavaprabhu","family":"Achappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Manibettu Raguram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitamahalakshminagasai","family":"Yerramsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,7]]},"reference":[{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.1","unstructured":"WHO, 2017. World Health Organization Press WHO Global tuberculosis report 2017 [Internet] http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02429.x"},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.3","unstructured":"Heather JC. A Case Report and Review of the Literature, 1968:116\u20138. 45(October)."},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.4","first-page":"93","article-title":"Isoniazid induced Pure Red blood cell aplasia","volume":"17","author":"Dixit","year":"2003","journal-title":"Indian j allergy asthma immunol"},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3201\/eid1309.061334","article-title":"Pure red blood cell aplasia and isoniazid use","volume":"13","author":"Loulergue","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V24.5.616.616","article-title":"A Case of red cell aplasia occurring as a result of antituberculous therapy","volume":"24","author":"GOODMAN","year":"1964","journal-title":"Blood"},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.7","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2169\/internalmedicine.8379-16","article-title":"Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature","volume":"56","author":"Saito","year":"2017","journal-title":"Intern Med"},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.62.1.71"},{"key":"2025042706293601000_2018.oct05_1.bcr-2018-226134.9","first-page":"41","article-title":"Isoniazid induced pure red cell aplasia","volume":"36","author":"Sen","year":"1989","journal-title":"Ind J Tub"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-226134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:29:46Z","timestamp":1745760586000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-226134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,7]]},"references-count":9,"alternative-id":["10.1136\/bcr-2018-226134"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-226134","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,7]]}}}